Transformez ce poste en entretien — un CV et une lettre de motivation conçus selon ce que cet employeur recherche.
Institut Curie in France invites applications for a 12-month, renewable contract in the CellAction Process Development group. The role focuses on developing and optimizing manufacturing processes for cell- and gene-based therapies, ensuring GMP compliance and robust, scalable workflows for clinical use.
The position requires 2–5 years in process development, a Master’s or PhD in biotechnology-related fields, and strong English communication; French is a plus. Starting date as soon as possible.
Organisation/Company Institut Curie - Research Center Department Administration Research Field Medical sciences » Cancer research Researcher Profile Recognised Researcher (R2) Positions PhD Positions Application Deadline 25 Nov 2026 - 00:00 (Europe/Paris) Country France Type of Contract Temporary Job Status Full-time Offer Starting Date 25 Sep 2026 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
The “Institut Curie” is a major player in the research and fight against cancer. It consists of a hospital and a Research Center of more than 1000 employees with a strong international representativeness.
The objective of the Curie Institute Research Center is to develop basic research and to use the knowledge produced to improve the diagnosis, prognosis, and therapeutics of cancers as part of the continuum between basic research and innovation serving the patient.
CellAction is part of Institut Curie’s commitment to building unique expertise in cell and gene therapy. It integrates multidisciplinary competencies in bioinformatics, target discovery and validation, molecular biology, genome editing, viral and non-viral vector design, cell engineering, and the development of in vitro and in vivo tumor models for cell and gene therapy applications. Furthermore, CellAction provides pre-GMP process development expertise, aiming to generate fully characterized, GMP-ready cell therapy products that can be manufactured in dedicated GMP facilities and subsequently evaluated in clinical settings.
In 2025, CellAction was permanently established at the Saint-Cloud site of Institut Curie.
At the Process Development group at CellAction, our activities focus on the development and optimization of manufacturing processes for cell- and gene-based therapies, ensuring translational feasibility and compliance with regulatory standards for clinical-grade production.
Identify innovative approaches to improve process efficiency and maintain technology watch in the field of cell and gene therapy.
2–5 years of experience in process development (cell therapy, gene therapy, or drug development)
Fluent in English; French is a plus
All our opportunities are open to individuals with disabilities.
Start date: As soon as possible
Contract duration: 12 months, renewable for an additional 12 months
Working time: Full-time – 39 hours per week
Salary:According to current salary scales
Benefits: Company cafeteria, 70% coverage of annual public transportation pass, company health insurance
Faithful to the legacy of its founder, the Institut Curie is deeply committed to promoting equal opportunities, diversity, and inclusion. Convinced that diversity of backgrounds and experiences contributes to collective performance, we strive to provide everyone with a respectful and equitable working environment and encourage all candidates to apply for our job opportunities.